You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Adenocarcinoma

Showing 26 - 50 of 8,125
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced Adenocarcinoma Trial (BA3182)

Not yet recruiting
  • Advanced Adenocarcinoma
  • (no location specified)
Apr 10, 2023

Pancreatic Ductal Adenocarcinoma, Pain, Acute Trial in San Francisco (Ketamine, Meaning and Purpose therapy)

Not yet recruiting
  • Pancreatic Ductal Adenocarcinoma
  • Pain, Acute
  • San Francisco, California
    University of California, San Francisco
Oct 12, 2023

Pancreatic Ductal Adenocarcinoma, Pancreas Adenocarcinoma, Pancreas Cancer Trial in Kansas City (Enfortumab vedotin)

Recruiting
  • Pancreatic Ductal Adenocarcinoma
  • +2 more
  • Enfortumab vedotin
  • Kansas City, Kansas
    University of Kansas Cancer Center
Jun 23, 2023

Adenocarcinoma of Stomach Trial in Shanghai (Gentuximab Injection, Gentuximab Injection Placebo)

Recruiting
  • Adenocarcinoma of Stomach
  • Gentuximab Injection
  • Gentuximab Injection Placebo
  • Shanghai, Shanghai, China
    Shanghai Dongfang Hospital
Jun 16, 2023

Locally Advanced Unresectable Pancreatic Adenocarcinoma Trial (Padeliporfin Vascular Targeted Photodynamic (VTP) therapy)

Not yet recruiting
  • Locally Advanced Unresectable Pancreatic Adenocarcinoma
  • Padeliporfin Vascular Targeted Photodynamic (VTP) therapy
  • (no location specified)
Jun 25, 2023

Gastric Cancer, Stomach Cancer, GastroEsophageal Cancer Trial in Kyiv (Docetaxel, Oxaliplatin, Leucovorin)

Recruiting
  • Gastric Cancer
  • +10 more
  • Kyiv, Ukraine
    National Cancer Institute
Aug 31, 2023

Most Total Pancreatectomies for Ductal Adenocarcinoma Can Be

Recruiting
  • Ductal Adenocarcinoma of the Pancreas
  • Whipple over the splenic artery
  • Total pancreatectomy
  • Taipei, Taiwan
    National Taiwan University Hospital
Nov 1, 2023

Novel Grading System of Resected Lung Adenocarcinoma

Recruiting
  • Lung Adenocarcinoma
  • +2 more
  • Whole Slide Image based Deep Learning Signature
  • Zunyi, Guizhou, China
  • +2 more
Jun 27, 2023

Advanced Duodenal Adenocarcinoma by Fuquinitinib Combined With

Not yet recruiting
  • Third-line Treatment
  • +2 more
  • furquimatinib and sintilimab
  • (no location specified)
Mar 30, 2023

Gastric Adenocarcinoma, Adenocarcinoma of Gastroesophageal Junction Trial in Guangzhou (Docetaxel for injection (Albumin-bound),

Recruiting
  • Gastric Adenocarcinoma
  • Adenocarcinoma of Gastroesophageal Junction
  • Docetaxel for injection (Albumin-bound)
  • Taxotere
  • Guangzhou, China
    Ethics Committee of Sun-Yat-Sen University Cancer Center
Jan 27, 2023

Gastric or Esophagogastric Junction Adenocarcinoma Trial (nimotuzumab plus paclitaxel, plus paclitaxel)

Not yet recruiting
  • Gastric or Esophagogastric Junction Adenocarcinoma
  • nimotuzumab plus paclitaxel
  • placebo plus paclitaxel
  • (no location specified)
Aug 3, 2023

Gastric, Colorectal Adenocarcinoma Trial in Shenyang (tislelizumab)

Not yet recruiting
  • Gastric
  • Colorectal Adenocarcinoma
  • Shenyang, Liaoning, China
    Liaoning Cancer Hospital & Institute
Nov 1, 2023

Intraoperative Frozen Section Pathology to Guide Surgical

Recruiting
  • Lung Adenocarcinoma
  • +2 more
  • Surgical resection
  • Shanghai, Shanghai, China
    Fudan University Cancer Center
Mar 20, 2023

Predicts Lymph Node Metastasis in Resectable Adenocarcinoma of

Completed
  • Pancreas Cancer
    • (no location specified)
    Jul 15, 2023

    Intraoperative Frozen Section Pathology to Guide Surgical

    Recruiting
    • Lung Adenocarcinoma
    • +2 more
    • Surgical resection
    • Shanghai, Shanghai, China
      Fudan University Cancer Center
    Mar 31, 2023

    PDAC - Pancreatic Ductal Adenocarcinoma Trial in Verona (ctDNA analysis)

    Recruiting
    • PDAC - Pancreatic Ductal Adenocarcinoma
    • ctDNA analysis
    • Verona, Italy
      AOUI Verona
    May 8, 2023

    Minimal Residual Disease Using Multi-omics Approach

    Not yet recruiting
    • Pancreatic Ductal Adenocarcinoma
    • Blood collection and Pancreatic ductal adenocarcinoma minimal residual disease detection test
    • Shanghai, China
      Department of Pancreatic and Hepatobiliary Surgery, Fudan Univer
    Nov 29, 2023

    Resected Pancreatic and Ampullary Adenocarcinoma at Favorable

    Enrolling by invitation
    • Resectable Pancreatic Adenocarcinoma
      • Milan, Italy
        National Cancer Institute of Milan
      Mar 3, 2023

      Cancer Of Pancreas Trial (Analyze of GemCore status)

      Not yet recruiting
      • Cancer Of Pancreas
      • Analyze of GemCore status
      • (no location specified)
      Sep 19, 2023

      Gastric Adenocarcinoma, Carcinomatosis Trial in Houston (Paclitaxel, Dexamethasone, Diphenhydramine)

      Not yet recruiting
      • Gastric Adenocarcinoma
      • Carcinomatosis
      • Houston, Texas
        M D Anderson Cancer Center
      Aug 7, 2023

      Gastric or Gastroesophageal Junction Adenocarcinoma Trial in Guangzhou (PD-1 inhibitor)

      Recruiting
      • Gastric or Gastroesophageal Junction Adenocarcinoma
      • PD-1 inhibitor
      • Guangzhou, China
        Sun Yat-sen University Cancer Center
      Aug 9, 2023

      18F-FAPI, 18F-FDG, Pancreas Adenocarcinoma Trial in Hangzhou (18F-FAPI, 18F-FDG)

      Completed
      • 18F-FAPI
      • +4 more
      • Hangzhou, Zhejiang, China
        the First Affiliated Hospital, School of Medicine, Zhejiang Univ
      May 31, 2023

      PDAC - Pancreatic Ductal Adenocarcinoma Trial (Combination of sitagliptin+ gemcitabine + nab-paclitaxel)

      Not yet recruiting
      • PDAC - Pancreatic Ductal Adenocarcinoma
      • Combination of sitagliptin+ gemcitabine + nab-paclitaxel
      • (no location specified)
      Jul 9, 2023

      Gastric Type Adenocarcinoma (GAS) With STK11 Mutation Trial in Shanghai (WX390, Toripalimab)

      Recruiting
      • Gastric Type Adenocarcinoma (GAS) With STK11 Mutation
      • Shanghai, Shanghai, China
        The Obstetrics & Gynecology Hospital of Fudan University (Shangh
      Nov 3, 2023

      Pancreatic Adenocarcinoma Trial in Dublin (Dose-Painted Intensity Modulated Radiotherapy)

      Not yet recruiting
      • Pancreatic Adenocarcinoma
      • Dose-Painted Intensity Modulated Radiotherapy
      • Dublin, Ireland
        St Luke's Radiation Oncology Network (SLRON)
      Aug 29, 2023